Senate Questions Food and Drug Administration Nominee Over Presidential Independence and Scientific Integrity
During a contentious confirmation hearing, bipartisan senators questioned the administration's FDA nominee regarding their willingness to resist executive political pressure on pharmaceutical and public health decisions.